—— 要投稿,上万维,轻松学术交流

严正声明

本站非期刊官网,非中介代理,
不向作者收取任何费用!
举报微信:13140028228 冯老师

态度公正、信息求实、投稿自助、使用免费
Journal of Clinical Lipidology《临床血脂学杂志》
双月刊 - 美国
  • Journal of Clinical Lipidology《临床血脂学杂志》
  • SCIE外文期刊
  • 期发文量18
  • 国人占比11.11%
  • 维普目次
  • 投稿方式--官网投稿
  • 期刊属性

  • 中科分区:3区
    OA期刊:混合
  • 综述期刊:
    TOP期刊:
  • 期均国文:2
    环比增速:400.00%
  • 期刊信息

  • 研究方向:医学-PHARMACOLOGY PHARMACY 药学
  • 国际刊号:ISSN1933-2874;EISSN1876-4789
  • 期刊语言:英语
    出版地区:美国
  • 投稿网址:https://www.editorialmanager.com/JCLINLIPID/default.aspx
  • 电子邮箱:
  • 期刊官网:https://www.journals.elsevier.com/journal-of-clinical-lipidology
  • 作者指南:
  • 出版商网址:http://www.elsevier.com
  • 出版地址:ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710
  • 期刊简介:Journal of Clinical Lipidology《临床血脂学杂志》(双月刊). The Journal of Clinical Lipidology is published to support the diverse array of medical professionals who work to reduce the incidence of morbidity and mortality from dyslipidemia and associated disorders of lipid metabolism. The Journals readership encompasses a broad cross-section of the medical community, including cardiologists, endocrinologists, and primary care physicians, as well as those involved in the treatment of such disorders as diabetes, hypertension, and obesity. The Journal also addresses allied health professionals who treat the patient base described above, such as pharmacists, nurse practitioners and dietitians.

  • 万维提示


  • 1、投稿方式:在线投稿

    2期刊网址:

    https://www.journals.elsevier.com/journal-of-clinical-lipidology

    3投稿网址:

    https://www.editorialmanager.com/JCLINLIPID/default.aspx

    4、期刊刊期:双月刊,一年出版6期。

    2021年8月20日星期

                                     

     

    投稿须知【官网信息】

     

    Guide for Authors

    The Journal of Clinical Lipidology is published to support the diverse array of medical professionals who work to reduce the incidence of morbidity and mortality from dyslipidemia and associated disorders of lipid metabolism.

    Journal of Clinical Lipidology provides rapid online electronic and print publication of the most important current scientific developments in the field of lipids and lipidology. The Journal publishes both clinical and basic original, peer-reviewed articles devoted to diagnosis and treatment lipid disorders. Sections of the Journal address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate.

    Manuscript Categories

    Original ArticlesOriginal articles generally should range between 2000 and 6000 words, and include no more than 40 references. Abstract, article structure, and optional supplementary (online only) material are described under Preparation requirements below.

    Case Studies Case studies are limited to 4 authors, 8 double-spaced pages total, including text, references (no more than 20), figure legends, and 3 figures. Abstract (up to 160 words) is optional; see Preparation requirements below.

    Reviews Contemporary and Historical Reviews (Solicited and Unsolicited). Review articles should contain a brief abstract (see Preparation requirements below) and generally should not exceed 5000 words, including references, tables, and figures. References should be limited to 45.

    Editorial Commentaries All editorials by invitation only. Commentaries should be confined to articles in the current issue or a very specific topic that is current and of high interest to the readership.

    Brief CommunicationsBrief communications may reflect new concise findings of high value, clinical implementation science, or illustrative cases with concise review. They should not exceed 2000 words, including text, tables, figure legends, and up to 20 references. Total number of tables and figures is limited to 3. An unstructured abstract should be included, up to 160 words.

    Letters to the EditorLetters should be double-spaced, not exceeding 450 words. No abstract. Letters will be reviewed and are subject to editing. If accepted for publication, a copy of the letter will be sent to the author(s) of the original article, if applicable. The author(s) will have an opportunity to respond with new material that will be considered for publication with the letter.

    News and Statements from the NLA News and Statements from the NLA are only for the National Lipid Association (NLA) to provide content: NLA news and upcoming event information, as well as abstracts from the NLA Annual Scientific Sessions, scientific and consensus statements, and scientific forums held by chapters, when appropriate.

    Submission checklist

    You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.

    Ensure that the following items are present:

    One author has been designated as the corresponding author with contact details:

    E-mail address

    Full postal address

    All necessary files have been uploaded:

    Manuscript:

    Include keywords

    All figures (include relevant captions)

    All tables (including titles, description, footnotes)

    Ensure all figure and table citations in the text match the files provided

    Indicate clearly if color should be used for any figures in print

    Graphical Abstracts / Highlights files (where applicable)

    Supplemental files (where applicable)

    ……

    更多详情:

    https://www.elsevier.com/journals/journal-of-clinical-lipidology/1933-2874/guide-for-authors







欢迎点评!让信息更透明,使投稿更轻松!
  • 审稿时间:
    是否录用:
  • 见刊周期:
    查重要求:
  • 有无课题:
    有无回复:
  • 我的学历:
    我的职称:
  • 审稿费用:
    版面费用:
  • 稿       费:
    稿件字数:
  • 投稿难度:
  • 该刊可发:
  • 投稿主题:
匿名: 验证码: 点击切换验证码
    评分:0

    验证码: 点击切换验证码